88 related articles for article (PubMed ID: 22586354)
1. The drug-induced degradation of oncoproteins: an unexpected Achilles' heel of cancer cells?
Ablain J; Nasr R; Bazarbachi A; de Thé H
Cancer Discov; 2011 Jul; 1(2):117-27. PubMed ID: 22586354
[TBL] [Abstract][Full Text] [Related]
2. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
[TBL] [Abstract][Full Text] [Related]
3. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.
Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H
Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868
[TBL] [Abstract][Full Text] [Related]
4. Acute promyelocytic leukemia: a paradigm for differentiation therapy.
Grimwade D; Mistry AR; Solomon E; Guidez F
Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254
[TBL] [Abstract][Full Text] [Related]
5. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia.
Zheng PZ; Wang KK; Zhang QY; Huang QH; Du YZ; Zhang QH; Xiao DK; Shen SH; Imbeaud S; Eveno E; Zhao CJ; Chen YL; Fan HY; Waxman S; Auffray C; Jin G; Chen SJ; Chen Z; Zhang J
Proc Natl Acad Sci U S A; 2005 May; 102(21):7653-8. PubMed ID: 15894607
[TBL] [Abstract][Full Text] [Related]
6. Targeting oncoproteins for degradation by small molecules in myeloid leukemia.
Lei H; Wang W; Wu Y
Leuk Lymphoma; 2018 Oct; 59(10):2297-2304. PubMed ID: 29198160
[TBL] [Abstract][Full Text] [Related]
7. Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission.
Zhu J; Lallemand-Breitenbach V; de Thé H
Oncogene; 2001 Oct; 20(49):7257-65. PubMed ID: 11704854
[TBL] [Abstract][Full Text] [Related]
8. Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway.
Huai L; Wang C; Zhang C; Li Q; Chen Y; Jia Y; Li Y; Xing H; Tian Z; Rao Q; Wang M; Wang J
Biochem Biophys Res Commun; 2012 Jun; 422(3):398-404. PubMed ID: 22575507
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
[TBL] [Abstract][Full Text] [Related]
10. IAP antagonists: promising candidates for cancer therapy.
Mannhold R; Fulda S; Carosati E
Drug Discov Today; 2010 Mar; 15(5-6):210-9. PubMed ID: 20096368
[TBL] [Abstract][Full Text] [Related]
11. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
Chen GQ; Zhou L; Styblo M; Walton F; Jing Y; Weinberg R; Chen Z; Waxman S
Cancer Res; 2003 Apr; 63(8):1853-9. PubMed ID: 12702573
[TBL] [Abstract][Full Text] [Related]
12. Retinoids in chemoprevention and differentiation therapy.
Hansen LA; Sigman CC; Andreola F; Ross SA; Kelloff GJ; De Luca LM
Carcinogenesis; 2000 Jul; 21(7):1271-9. PubMed ID: 10874003
[TBL] [Abstract][Full Text] [Related]
13. Autophagic degradation of an oncoprotein.
Bøe SO; Simonsen A
Autophagy; 2010 Oct; 6(7):964-5. PubMed ID: 20724820
[TBL] [Abstract][Full Text] [Related]
14. Curing APL through PML/RARA degradation by As2O3.
Lallemand-Breitenbach V; Zhu J; Chen Z; de Thé H
Trends Mol Med; 2012 Jan; 18(1):36-42. PubMed ID: 22056243
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell metabolism: cancer's Achilles' heel.
Kroemer G; Pouyssegur J
Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
[TBL] [Abstract][Full Text] [Related]
16. [Arsenic and retinoic acid, towards targeted treatments of acute promyelocytic leukemia?].
de Thé H
Bull Acad Natl Med; 1998; 182(1):63-71. PubMed ID: 9622932
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid receptors, hematopoiesis and leukemogenesis.
Collins SJ
Curr Opin Hematol; 2008 Jul; 15(4):346-51. PubMed ID: 18536573
[TBL] [Abstract][Full Text] [Related]
18. Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid.
Jiang G; Albihn A; Tang T; Tian Z; Henriksson M
Leuk Res; 2008 Feb; 32(2):297-307. PubMed ID: 17706770
[TBL] [Abstract][Full Text] [Related]
19. Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway.
Zhao XY; He ZW; Wu D; Xu RZ
Chin Med J (Engl); 2007 May; 120(9):802-6. PubMed ID: 17531122
[TBL] [Abstract][Full Text] [Related]
20. The microculture-kinetic (MiCK) assay: the role of a drug-induced apoptosis assay in drug development and clinical care.
Bosserman L; Prendergast F; Herbst R; Fleisher M; Salom E; Strickland S; Raptis A; Hallquist A; Perree M; Rajurkar S; Karimi M; Rogers K; Davidson D; Willis C; Penalver M; Homesley H; Burrell M; Garrett A; Rutledge J; Chernick M; Presant CA
Cancer Res; 2012 Aug; 72(16):3901-5. PubMed ID: 22865459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
